Arrowhead Pharmaceuticals, Inc. (ARWR)
73.34
-0.52
(-0.70%)
USD |
NASDAQ |
Jun 09, 16:00
73.34
0.00 (0.00%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Shareholders Equity (Quarterly) : 613.98M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.505B |
| Revolution Medicines, Inc. | 1.500B |
| Kymera Therapeutics, Inc. | 1.540B |
| ImmunityBio, Inc. | -870.01M |
| Vera Therapeutics, Inc. | 499.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.268B |
| Total Liabilities (Quarterly) | 1.669B |
| Debt to Equity Ratio | 2.237 |
| Current Ratio | 6.232 |
| Net Debt Paydown Yield | -1.14% |